ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    nct02239120
Previous Study | Return to List | Next Study

Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02239120
Recruitment Status : Active, not recruiting
First Posted : September 12, 2014
Last Update Posted : June 20, 2018
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : August 10, 2018
  Estimated Study Completion Date : August 10, 2018